Sarissa Capital Management as of March 31, 2015
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 17 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 22.3 | $106M | 13M | 8.24 | |
| Abbvie (ABBV) | 19.5 | $93M | 1.6M | 58.54 | |
| Quest Diagnostics Incorporated (DGX) | 12.6 | $60M | 775k | 76.85 | |
| Amgen (AMGN) | 10.7 | $51M | 318k | 159.85 | |
| Aegerion Pharmaceuticals | 9.0 | $43M | 1.6M | 26.17 | |
| Medicines Company | 7.2 | $34M | 1.2M | 28.02 | |
| Merck & Co (MRK) | 4.8 | $23M | 400k | 57.48 | |
| Flamel Technologies Sa Sponsored Adr | 3.3 | $16M | 875k | 17.98 | |
| Apricus Bioscience | 2.6 | $12M | 6.5M | 1.87 | |
| Repros Therapeutics Com New | 2.1 | $9.7M | 1.1M | 8.59 | |
| Intra Cellular Therapies (ITCI) | 1.8 | $8.6M | 360k | 23.88 | |
| Vivus | 1.3 | $6.3M | 2.6M | 2.46 | |
| Kindred Biosciences | 1.0 | $4.9M | 689k | 7.14 | |
| AVEO Pharmaceuticals | 0.8 | $3.7M | 2.6M | 1.45 | |
| Biosante Pharmaceuticals (ANIP) | 0.4 | $1.9M | 31k | 62.55 | |
| Targacept | 0.4 | $1.9M | 630k | 2.97 | |
| Eleven Biotherapeutics | 0.1 | $368k | 41k | 8.93 |
